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ABSTRACT 
 
Five commercial LaSota strain Newcastle disease (ND) vaccines namely A, B, C, D and E were 
evaluated for their potency, efficacy, thermostability and influence on productivity in broilers. A 3-log10 
difference of EID50 and two-to-eight fold difference of HA activity was found among the various vaccines 
tested. One hundred and fifty day-old broiler chicks were divided into six equal groups tagged as I, II, III, 
IV, V and VI. The birds in groups I, II, III, IV and V were actively immunized against ND on days 7 (eye 
drop method) and 21 (drinking water) using vaccines A, B, C, D and E, respectively. The birds in group VI 
served as unvaccinated control. The serum HI antibody response to five vaccines was determined 7, 14, 21 
and 28 days post-vaccination. Fifteen birds from each group including unvaccinated control were 
challenged at day 35 with local virulent ND field isolate. The HI serum antibody profile and post-challenge 
mortality pattern revealed a dose-response relation between the virus content, humoral antibody response 
and clinical protection. To compare the heat stability, the vaccines were incubated at 4, 25 and 40
0C for a 
period of 24 hours. There was no remarkable reduction in HA titer, however slight dips (less than 2 
logarithmic units) in EID50 values were found in all the vaccines. All the vaccines caused significant 
suppression in weight gain, leading to a poor performance in terms of feed conversion ratio (FCR) and 
European Efficiency Factor (EEF).  
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INTRODUCTION 
 
 Newcastle disease (ND) is a highly contagious 
viral disease, which affects almost all species of 
domestic and wild birds. This disease is caused by a 
virus of genus Avulovirus, subfamily Paramyxovirinae, 
family Paramyxoviridae (Al-Garib et al., 2003). The 
disease was first recognized in Indonesia and England 
in 1926 (Doyle, 1927) and ND viruses are now found 
worldwide. In Pakistan, ND outbreaks are still 
common, despite the use of massive immunization 
against ND in various kinds of commercial poultry such 
as layers, broilers and breeding flocks. The signs of ND 
can range from no symptoms or mild air sacculitis to 
severe nervous and/or visceral involvement, leading to 
paralysis and death of the infected chickens.  
In Pakistan, the broiler chickens are routinely 
vaccinated against ND using various routes of 
vaccination such as drinking water, intraocular, 
intranasal and aerosol spray. The age of the chicks at 
vaccination and the level of maternally derived 
antibody greatly influence immune response of broiler 
chickens to the vaccinal antigen.  There has been a 
concern in the broiler industry that ND vaccines being 
used in Pakistan may not be provoking desired level of 
antibody response and as such the required protection. 
Therefore, the purpose of this investigation was to 
compare five major commercial ND (LaSota) vaccines 
being marketed in Pakistan for use in broiler chickens 
with respect to potency, efficacy, thermostability and 
influence on productivity.  
MATERIALS AND METHODS 
 
Vaccines 
The representative vials of five major brands of the 
live NDV LaSota strain vaccines namely A, B, C, D 
and E were procured from the local market. The 
vaccines were evaluated for their potency, efficacy, 
thermostability and influence on productivity of 
broilers. 
 
Potency testing 
The vaccines were assayed for 50% infectivity 
(EID50) and haemagglutinating activity (HA) using eggs 
from desi (local) hens. The EID50 of the vaccines was 
determined using the technique of Reed and Muench 
(1938). Similarly, HA titer was determined by treating 
50 ul of virus suspension in each vaccine vial with 50 ul 
of 0.5% chicken RBCs suspended in normal saline and 
by incubating the test material at room temperature for 
30 minutes according to the procedure suggested by 
Allan and Gough (1974).  
 
Efficacy testing  
One hundred and fifty day-old broiler chicks were 
divided into six equal groups (n=25) tagged as I, II, III, 
IV, V and VI and were managed separately to prevent 
cross contamination or horizontal spread of vaccinal 
virus. The birds in groups I, II, III, IV and V were 
actively immunized against ND on day 7 (eye drop 
method) and 21 (drinking water) using vaccines A, B, 
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C, D and E, respectively. The birds in group VI served 
as unvaccinated controls. The serum HI antibody 
response to different vaccines was determined 7, 14, 21 
and 28 days post-vaccination. Fifteen birds from each 
group including unvaccinated control were challenged 
on day 35 with velogenic NDV field isolate.  
Table 2: Comparison of NDV geometric mean HI 
titers (log ) of the broiler chickens primed 
on day 7 and boosted at day 21 with live 
NDV LaSota strain vaccines
2
HI titer (log 2) at days post-vaccination  Vaccine 
source  1 7 14 21 28
A  2.25 2.75 3.25 5.13 5.25 
B  1.25 3.75 4.00 5.75 5.63 
C  2.00 3.00 3.50 4.80 5.00 
D  1.50 3.00 3.20 5.38 5.38 
E  1.75 2.00 2.25 3.00 3.25 
 
Thermostability and productivity 
To compare the heat stability, five vaccines were 
incubated at 4, 25 and 40
0C for a period of 24 hours. 
The trends in decline in EID50 and HA titers were 
monitored.  
The average weight gain and feed consumption 
were measured for birds of each group on weekly basis. 
The performance of the birds was evaluated on the 
basis of feed conversion ratio (FCR) and European 
Efficiency Factor (EEF). The FCR and EEF were 
calculated using the following formulas:  
FCR= feed consumed (g) / weight gain (g) 
EEF = (Livability (%) x live weight (kg)) / (age (days) 
x feed conversion ratio) x 100, 
Where: 
Livability = 100 - (% dead + % rejected). 
 
Statistical analysis 
The data collected through the study from various 
treatment groups were compared by one-way analysis 
of variance. Differences among treatment means were 
compared using Least Significant Difference (LSD) test 
at 5% probability level (Steel and Torrie, 1980). 
 
RESULTS AND DISCUSSION 
  
A 3-log10 difference of EID50 and two-to-eight fold 
difference of HA activity was found among five 
vaccines (Table 1). The minimum virus level for live 
virus LaSota strain ND vaccines is 10
6.5/dose (Hofacre, 
1986). All but one (vaccine E) of the commercial 
vaccines titered for this study was above this level. 
Hofacre (1986) compared the potential of high and low 
titered commercial ND vaccines and recorded 2-log10 
difference of virus titer elicited by the vaccines.  
All the vaccine brands indicated similar trends in 
antibody production. In the inoculated groups, however, 
the HI titer differed non-significantly among the 
vaccinated groups except for the vaccine E that 
provoked relatively weaker primary and secondary 
immune responses in terms of HI antibody production 
(Table 2).  
Following challenge of vaccinated birds in various 
groups, protection levels of 22, 7, 13, 20 and 40 percent 
were recorded for vaccines A, B, C, D and E, 
respectively. All the unvaccinated control chickens 
challenged on the same day succumbed to infection 
indicating 100 percent mortality (Table 3). The 
challenge-protection study revealed that the degree of 
protection conferred by the vaccines could be related to 
serum HI antibody profile of chickens. 
Table 3: Post-challenge mortality in chicks receiving 
live NDV LaSota strain vaccine from 
various sources  
Vaccine source 
 Mortality  
A 3/15(20%) 
B 1/15(7%) 
C 2/15(13%) 
D 3/15(20%) 
E 6/15(40%) 
control 15/15(100%) 
A dose-response relationship has been reported 
among the virus content, serological response and 
clinical protection (Spradbrow et al., 1988) in the host 
chicks. Brugh and Siegel (1978) determined the effect 
of virus concentration on serum antibody levels and 
concluded that the virus concentration had significant 
effects on immunogensity of the vaccines. Stone (1985) 
presented HA activity of oil-emersion ND virus 
vaccines as a prediction of efficacy. He related HA 
activity of the vaccines to degree of protection 
conferred against velogenic viscerotropic (VV) ND. 
Maas (2003) also investigated correlation of 
haemagglutinin-neuraminidase and fusion protein 
content of killed ND vaccines with haemagglutination-
inhibition (HI) antibody response in the chickens. 
During the present study the comparative heat 
stability of various vaccine brands was also evaluated 
by treating the vaccine vials at 4, 25 and 40
0C for 24 
hours and the effects of temperature on the HA titers 
and EID50 of virus were recorded. This study did not 
reveal any measurable reduction in the HA titers. 
However, the infectivity potential of virus decreased by 
less than 2 logarithmic units depending upon storage 
temperature (Table 4). The HA activity was more 
thermostable than the virus infectivity. 
Table 1: Comparative EID50 and HA activities of  five 
commercial live ND (LaSota strain) vaccines 
Vaccine source  EID50 HA titer 
A 10
7.78 512 
B 10
8.80 1024 
C 10
8.32 512 
D 10
7.31 512 
E 10
4.83 128 
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Abdu  et al. (1998) also studied the effects of 
storage conditions and temperature on efficacy of ND 
virus LaSota vaccine. The persistence of 
immunogenicity by incubation at room temperature for 
variable storage duration reveals the viability of the 
vaccines. Heath et al. (1991) studied the thermostability 
of V4 strain of NDV vaccine. The commercial vaccine 
in freeze-dried form remained stable upto 3 months at 
18-22
0C. Tu et al. (1998) showed that the freeze-dried 
ND vaccines lost about 1 log of infectivity upon its 
storage for 24 days at 30-35
0C.  
Significant differences in the average weight gain 
were observed amongst the vaccinated and 
unvaccinated groups of chickens. The vaccinated birds 
were found less efficient in converting feed than the 
unvaccinated birds and in all ND LaSota vaccinated 
groups weight gain was suppressed (Tables 5 and 6).   
 Alexander  et al. (2004) also described the 
suppressive effect of NDV LaSota strain on weight gain 
of chickens. The heavy breeds showed more adverse 
reaction to lentogenic ND viruses. Saif and Nestor 
(2002) found a positive correlation between increase in 
the body weight and the increase in mortality following 
vaccination with the live LaSota vaccine. Westbury et 
al. (1984) compared the residual virulence of Newcastle 
disease vaccines strains V4, Hitchner B1 and LaSota in 
terms of weight gain and number of sneezes. Tu et al. 
(1998) also determined the adverse effect of LaSota 
vaccines in comparison with ND virus isolates, a 
thermostable Newcastle disease virus vaccine in 
experimental and village chickens.  
Table 4: Effect of temperature treatment on the 
infectivity and haemagglutination
activity of the NDV vaccines 
Temperature 
4
0C 25
0C 40
0C 
Vaccine  
EID50 HA EID50 HA EID50 HA 
A 10
7.78 512 10
7.41 512 10
6.83 512 
B 10
8.80 1024  10
8.36 1024  10
7.76 1024 
C 10
8.32 512 10
7.94 512 10
7.41 512 
D 10
7.31 512 10
6.89 512 10
6.27 512 
E 10
4.83 128 10
4.36 128 10
3.89 128 
Table 6: Effect of commercial LaSota strain 
Newcastle disease vaccines on 
European Efficiency Factor (EEF) in 
broiler chicks  
Vaccine Liveablity 
(%) 
Live 
weight 
 (Kg) 
Age  
( days) 
FCR EEF* 
A 80  1527  42  1.795  522 
B 93  1588  42  1.777  625 
C 87  1563  42  1.794  581 
D 80  1534  42  1.811  529 
E 60  1471  42  1.772  372 
Control 97  1623  42  1.759  596 
*The minimum acceptable value of EEF is 260; the 
bigger the value the better the performance.  
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